USD 1.03
(0.0%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 | -1.05 Billion JPY | -97.94% |
2023 | 873 Million JPY | 16.54% |
2022 | -482 Million JPY | -15.46% |
2021 | 873 Million JPY | 439.66% |
2020 | -179 Million JPY | 0.0% |
2019 | -397 Million JPY | 32.96% |
2018 | -284 Million JPY | -186.61% |
2017 | -304 Million JPY | 199.09% |
2016 | -1.01 Billion JPY | 48.09% |
2015 | -1.56 Billion JPY | -41.78% |
2014 | -975 Million JPY | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | 15 Million JPY | -178.46% |
2024 Q1 | 221 Million JPY | 190.65% |
2024 Q3 | -175 Million JPY | 83.74% |
2024 FY | - JPY | -276.79% |
2024 Q4 | -476 Million JPY | 120.17% |
2023 Q4 | 246 Million JPY | 250.0% |
2023 Q1 | 512 Million JPY | 81.56% |
2023 Q2 | 5 Million JPY | -99.02% |
2023 Q3 | -164 Million JPY | -3380.0% |
2023 FY | - JPY | 16.54% |
2022 FY | - JPY | -15.46% |
2022 Q4 | 282 Million JPY | 547.62% |
2022 Q3 | -63 Million JPY | -1.61% |
2022 Q2 | -62 Million JPY | 64.57% |
2022 Q1 | -175 Million JPY | -257.66% |
2021 Q2 | 495 Million JPY | 838.81% |
2021 Q4 | 111 Million JPY | 582.61% |
2021 FY | - JPY | 439.66% |
2021 Q1 | -67 Million JPY | -123.33% |
2021 Q3 | -23 Million JPY | -104.65% |
2020 Q4 | -30 Million JPY | -109.17% |
2020 Q3 | 327 Million JPY | 524.68% |
2020 FY | - JPY | 0.0% |
2020 Q1 | 388 Million JPY | 227.21% |
2020 Q2 | -77 Million JPY | -119.85% |
2019 Q3 | 167 Million JPY | 209.26% |
2019 FY | - JPY | 32.96% |
2019 Q1 | -96 Million JPY | -43.92% |
2019 Q2 | 54 Million JPY | 156.25% |
2019 Q4 | -305 Million JPY | -282.63% |
2018 Q4 | -66.7 Million JPY | -373.03% |
2018 FY | - JPY | -186.61% |
2018 Q3 | 24.43 Million JPY | 225.73% |
2018 Q2 | -19.43 Million JPY | 88.28% |
2018 Q1 | -165.78 Million JPY | -32.87% |
2017 Q2 | 552.69 Million JPY | 274.85% |
2017 Q1 | -316.09 Million JPY | -171.53% |
2017 Q4 | -124.77 Million JPY | 13.79% |
2017 Q3 | -144.72 Million JPY | -126.19% |
2017 FY | - JPY | 199.09% |
2016 Q2 | -106.71 Million JPY | 58.63% |
2016 Q4 | -116.41 Million JPY | 30.14% |
2016 FY | - JPY | 48.09% |
2016 Q3 | -166.64 Million JPY | -56.15% |
2016 Q1 | -257.96 Million JPY | -95.57% |
2015 Q1 | -186 Million JPY | -16.54% |
2015 Q2 | -181.08 Million JPY | 2.65% |
2015 Q4 | -131.9 Million JPY | 57.38% |
2015 FY | - JPY | -41.78% |
2015 Q3 | -309.47 Million JPY | -70.91% |
2014 FY | - JPY | 0.0% |
2014 Q4 | -159.61 Million JPY | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
AVITA Medical, Inc. | -39.56 Million USD | -2576.421% |
Manhattan Scientifics, Inc. | -1.16 Million USD | -90879.381% |
Össur hf. | 137.38 Million USD | 870.849% |
QHSLab, Inc. | -91.29 Thousand USD | -1159901.314% |
Wellstar International, Inc. | -1.35 Million USD | -77967.523% |
Össur hf. | 137.38 Million USD | 870.849% |
CVR Medical Corp. | - USD | Infinity% |
Bionovate Technologies Corp | - USD | Infinity% |
Escalon Medical Corp. | -58.46 Thousand USD | -1811364.053% |
Aurora Spine Corporation | -454.37 Thousand USD | -232965.861% |
BrainsWay Ltd. | -2.31 Million USD | -45724.318% |
Lattice Biologics Ltd. | - USD | Infinity% |
BioElectronics Corporation | -274.29 Thousand USD | -385987.717% |
Hamilton Thorne Ltd. | 5.52 Million USD | 19279.137% |
Vivos Inc. | -2.79 Million USD | -37814.237% |
Kelyniam Global, Inc. | -197.69 Thousand USD | -535584.477% |
REMSleep Holdings, Inc. | -1.66 Million USD | -63368.129% |
Zecotek Photonics Inc. | -3.44 Million USD | -30665.038% |
Avitar, Inc. | -1.66 Million USD | -63396.708% |
Nanomix Corporation | -8.13 Million USD | -12910.2% |
EKF Diagnostics Holdings plc | 9.77 Million USD | 10934.765% |
Theraclion SA | -2.05 Million USD | -51538.738% |
Lifeline Biotechnologies, Inc. | - USD | Infinity% |
Positron Corporation | -1.45 Million USD | -72826.3% |
Rafina Innovations Inc. | - USD | Infinity% |
Electromedical Technologies, Inc. | -1.72 Million USD | -61402.365% |
Lombard Medical, Inc. | -28.06 Million USD | -3672.98% |
ALR Technologies Inc. | -6.4 Million USD | -16446.061% |
Stratec SE | 39.91 Million USD | 2753.204% |
Vycor Medical, Inc. | 100.94 Thousand USD | 1049206.922% |
Heart Tronics, Inc. | -14.85 Million USD | -7028.012% |
MicroPort Scientific Corporation | -347.57 Million USD | -204.68% |
VMS Rehab Systems, Inc. | -68.55 USD | -1544857668.053% |
NewCardio, Inc. | -9.37 Million USD | -11190.789% |
Guided Therapeutics, Inc. | -3.12 Million USD | -33777.159% |
Ingen Technologies, Inc. | -8639.00 USD | -12258263.236% |
Odyssey Group International, Inc. | -2.13 Million USD | -49430.559% |
CYduct Diagnostics, Inc. | -378.9 Thousand USD | -279388.844% |
Wellness Center USA, Inc. | -707.03 Thousand USD | -149681.48% |
SANUWAVE Health, Inc. | -9.15 Million USD | -11471.243% |
IR-Med Inc. | -4.89 Million USD | -21547.588% |
Perimeter Medical Imaging AI, Inc. | -13.27 Million USD | -7876.291% |
Polarean Imaging plc | -11.19 Million USD | -9359.588% |
United American Healthcare Corporation | -59 Thousand USD | -1794815.254% |
ECGI Holdings, Inc. | -2.99 Million USD | -35312.944% |
Nu-Med Plus, Inc. | -118.25 Thousand USD | -895392.098% |
Capital Group Holdings, Inc. | -629.18 Thousand USD | -168213.511% |
ADM Tronics Unlimited, Inc. | -514.02 Thousand USD | -205921.108% |
Medical Supply International USA, Inc. | 456.06 Thousand USD | 232306.289% |
Urologix, Inc. | -6.34 Million USD | -16592.938% |
Rapid Therapeutic Science Laboratories, Inc. | -1.23 Million USD | -85347.259% |
Nexeon MedSystems Inc. | -765.96 Thousand USD | -138156.609% |
SS Innovations International, Inc. | -20.37 Million USD | -5097.293% |
Qualis Innovations, Inc. | -222.81 Thousand USD | -475175.786% |
Smith & Nephew plc | 1 Billion USD | 205.627% |
NIOX Group Plc | 11.07 Million USD | 9661.99% |
Fuse Medical, Inc. | 1.83 Million USD | 57801.235% |
Broncus Holding Corporation | -25.19 Million USD | -4102.579% |
Brain Scientific Inc. | -7.93 Million USD | -13248.079% |
Pressure BioSciences, Inc. | -9.39 Million USD | -11176.87% |
Health Logic Interactive Inc. | -18.4 Thousand USD | -5755334.783% |